Menu

Experience

Richard Segal

    • Innate Pharma - $79 Million IPO 


    • SpringWorks Therapeutics – $186 Million IPO  


    • Bellus Health – $70 Million IPO  


    • Karuna Therapeutics $103 million IPO 


    • Morphic Therapeutics - $104 Million IPO 


    • Akero Therapeutics - $106 Million IPO 


    • Bicycle Therapeutics - $61 Million IPO 


    • Stealth BioTherapeutics $78 Million IPO 


    • LogicBio Therapeutics – $80.5 Million IPO 


    • Endava – $146 Million IPO 


    • Endava – $146 Million IPO 


    • MeiraGTx – $75 Million IPO 


    • Cardlytics – $76 Million IPO 


    • Cooley Advises on Nightstar + NuCana IPOs 


    • Neon Therapeutics – $100 Million IPO 


    • Syros – $58 Million IPO 


    • Syros IPO – $58 Million 


    • Voyager Therapeutics - $80.5 Million IPO 


    • Rapid7 - $118 IPO 


    • Celyad Completes IPO 


    • DBV Technologies – $281.5 Million Follow-On Offering  


    • NetScout Systems to Acquire Danaher Communications Business for $2.6B 


    • Minerva – $58 Million Follow-On Offering 


Contact us

Back to top

© 2019 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.